tradingkey.logo

Elanco Animal Health Inc

ELAN
View Detailed Chart
22.305USD
+0.215+0.97%
Close 12/19, 16:00ETQuotes delayed by 15 min
11.08BMarket Cap
308.38P/E TTM

Elanco Animal Health Inc

22.305
+0.215+0.97%
Intraday
1m
30m
1h
D
W
M
D

Today

+0.97%

5 Days

+4.77%

1 Month

+5.01%

6 Months

+65.71%

Year to Date

+84.19%

1 Year

+91.79%

View Detailed Chart

Key Insights

Elanco Animal Health Inc's fundamentals are relatively healthy, and its growth potential is high.Its valuation is considered fairly valued, ranking 24/158 in the Pharmaceuticals industry.Institutional ownership is very high.Over the past month, multiple analysts have rated it as Buy, with the highest price target at 25.15.In the medium term, the stock price is expected to trend up.Despite an average stock market performance over the past month, the company shows strong fundamentals and technicals.The stock price is trading sideways between the support and resistance levels, making it suitable for range-bound swing trading.

Elanco Animal Health Inc's Score

Industry at a Glance

Industry Ranking
24 / 158
Overall Ranking
74 / 4582
Industry
Pharmaceuticals

Support & Resistance

Relevant data have not been disclosed by the company yet.

Score Analysis

Current score
Previous score

Analyst Rating

Based on 16 analysts
Buy
Current Rating
25.154
Target Price
+15.97%
Upside Space
Data disclaimer: Analyst ratings and target prices are provided by LSEG for informational purposes only and do not constitute investment advice.

Elanco Animal Health Inc Highlights

StrengthsRisks
Elanco Animal Health Incorporated is an animal health company delivering products and services to prevent and treat disease in farm animals and pets. The Company's product portfolio is sold in more than 90 countries and serves animals across many species, primarily dogs and cats (collectively, pet health) and cattle, poultry, swine, and sheep (collectively, farm animal). It has a diverse portfolio of products marketed under approximately 200 brands, including products for both pets and farm animals. The Company's global pet health portfolio is focused on parasiticides, vaccines and therapeutics. Its pet health products include Advantage Family, Atopica, Credelio Family, Drontal Family, Galliprant, Interceptor Plus, Milbemax, Onsior, Seresto, Trifexis, and TruCan. Its farm animal products include AviPro, Baytril, Catosal, Denagard, Experior, Hemicell, Maxiban/Monteban, Pulmotil, Rumensin, and Surmax. Its customers include consultants, veterinarians, farm animal producers and resellers.
Turnaround to Profit
The company's performance has turned profitable, with the latest annual net income of USD .
Overvalued
The company’s latest PE is 308.31, at a high 3-year percentile range.
Institutional Buying
The latest institutional holdings are 577.24M shares, increasing 0.01% quarter-over-quarter.
Held by Chuck Royce
Star Investor Chuck Royce holds 602.56K shares of this stock.
Higher Market Activity
The company has more investor interest, with a 20-day turnover ratio of 1.06.

Elanco Animal Health Inc News

More news coming soon, stay tuned...

Financial Indicators

EPS

Relevant data have not been disclosed by the company yet.

Total revenue

Relevant data have not been disclosed by the company yet.

Elanco Animal Health Inc Info

Elanco Animal Health Incorporated is an animal health company delivering products and services to prevent and treat disease in farm animals and pets. The Company's product portfolio is sold in more than 90 countries and serves animals across many species, primarily dogs and cats (collectively, pet health) and cattle, poultry, swine, and sheep (collectively, farm animal). It has a diverse portfolio of products marketed under approximately 200 brands, including products for both pets and farm animals. The Company's global pet health portfolio is focused on parasiticides, vaccines and therapeutics. Its pet health products include Advantage Family, Atopica, Credelio Family, Drontal Family, Galliprant, Interceptor Plus, Milbemax, Onsior, Seresto, Trifexis, and TruCan. Its farm animal products include AviPro, Baytril, Catosal, Denagard, Experior, Hemicell, Maxiban/Monteban, Pulmotil, Rumensin, and Surmax. Its customers include consultants, veterinarians, farm animal producers and resellers.
Ticker SymbolELAN
CompanyElanco Animal Health Inc
CEOSimmons (Jeffrey N)
Websitehttps://www.elanco.com/

FAQs

What is the current price of Elanco Animal Health Inc (ELAN)?

The current price of Elanco Animal Health Inc (ELAN) is 22.305.

What is the symbol of Elanco Animal Health Inc?

The ticker symbol of Elanco Animal Health Inc is ELAN.

What is the 52-week high of Elanco Animal Health Inc?

The 52-week high of Elanco Animal Health Inc is 23.700.

What is the 52-week low of Elanco Animal Health Inc?

The 52-week low of Elanco Animal Health Inc is 8.020.

What is the market capitalization of Elanco Animal Health Inc?

The market capitalization of Elanco Animal Health Inc is 11.08B.

What is the net income of Elanco Animal Health Inc?

The net income of Elanco Animal Health Inc is 338.00M.

Is Elanco Animal Health Inc (ELAN) currently rated as Buy, Hold, or Sell?

According to analysts, Elanco Animal Health Inc (ELAN) has an overall rating of Buy, with a price target of 25.154.

What is the Earnings Per Share (EPS TTM) of Elanco Animal Health Inc (ELAN)?

The Earnings Per Share (EPS TTM) of Elanco Animal Health Inc (ELAN) is 0.072.
KeyAI